e-learning
resources
Stockholm 2007
Monday 17.09.2007
Cystic fibrosis: better diagnosis, improved progress, but long-term complications
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diffusion capacity pattern in potential lung transplant recipients with cystic fibrosis at an Irish centre
S. H. Chotirmall, P. Branagan, R. Conway, A. Mann, C. O‘Donohoe, N. G. McElvaney (Dublin, Ireland)
Source:
Annual Congress 2007 - Cystic fibrosis: better diagnosis, improved progress, but long-term complications
Session:
Cystic fibrosis: better diagnosis, improved progress, but long-term complications
Session type:
Thematic Poster Session
Number:
2310
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. H. Chotirmall, P. Branagan, R. Conway, A. Mann, C. O‘Donohoe, N. G. McElvaney (Dublin, Ireland). Diffusion capacity pattern in potential lung transplant recipients with cystic fibrosis at an Irish centre. Eur Respir J 2007; 30: Suppl. 51, 2310
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lane-hamilton syndrome and CCF: a fatal association
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Survival and lung function in double lung transplant recipients with cystic fibrosis
Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome
Year: 2017
Ciliary function in paediatric non cystic fibrosis (CF) lung transplant recipients
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009
Factors affecting lung function in adult cystic fibrosis patients after lung transplantation.
Source: International Congress 2018 – Evolving approaches to differential diagnosis
Year: 2018
Exercise capacity following lung transplantation in cystic fibrosis patients
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008
Survival benefit of lung transplantation for cystic fibrosis in Norway
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019
Lung function decline in a modern cystic fibrosis cohort
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012
Propofol sedation in lung transplant recipients: the impact of cystic fibrosis.
Source: Virtual Congress 2021 – Cystic fibrosis
Year: 2021
The need for lung transplantation in cystic fibrosis (CF) in the era of new treatment
Source: Virtual Congress 2020 – Lung transplantation in the era of new drugs
Year: 2020
Exercise tolerance in children with cystic fibrosis undergoing lung transplantation assessment
Source: Eur Respir J 2001; 18: 293-297
Year: 2001
Mortality risk and pulmonary function in adults with cystic fibrosis at time of wait listing for lung transplantation in the United States
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015
Difficult issues in the selection of cystic fibrosis patients for lung transplantation
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=139
Year: 2006
Lung function in children with cystic fibrosis liver disease
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021
Paediatric lung transplantation
Source: Eur Respir J 2004; 24 : 839-845
Year: 2004
Lung clearance index is reproducible and close to normal in stable cystic fibrosis patients post bilateral lung transplant
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009
Exercise testing in paediatric lung tranplant candidates with cystic fibrosis
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010
Exhaled biomarkers in patients with cystic fibrosis and lung transplant recipients
Source: Eur Respir J 2003; 22: Suppl. 45, 267s
Year: 2003
Combined bilateral lung and pancreatic islets transplantation from the same donor in two patients with cystic fibrosis
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009
Lung transplantation for cystic fibrosis
Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results
Year: 2015
Lung transplantation for cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 236-245
Year: 2014
Cystic fibrosis lung disease and lung transplantation
Source: ERS Skills Course 2016
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept